PET/CT scans can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment, according to a study presented at the ARRS annual meeting.
PET/CT scans can confirm a suspected colorectal cancer recurrence at an early stage, helping significantly in treatment, according to a study presented at the ARRS annual meeting.
Researchers at The Christie NHS Foundation Trust in Manchester, U.K., found 71 patients with suspected co-lorectal recurrence. Suspicion was based on CT and MR in 51 cases. The rest had a suspected recurrence based on a carcinoembryonic antigen test with unremarkable conventional imaging.
All 71 patients had a PET/CT scan to confirm or negate recurrence. The modality accurately confirmed a recurrence in 40 of 71 patients.
“This shows that PET/CT has a definite role in the management of patients with recurrent colorectal cancer in addition to conventional imaging and the CEA test,” said Dr. Rohit Kochhar, lead author of the study.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.